SUMOylation of HMGA2: selective destabilization of promyelocytic leukemia protein via proteasome. - Wikidata - wikimedia - TriplyDB

SUMOylation of HMGA2: selective destabilization of promyelocytic leukemia protein via proteasome.

SUMOylation of HMGA2: selective destabilization of promyelocytic leukemia protein via proteasome.

http://www.wikidata.org/entity/Q33824136

about

HMG modifications and nuclear function.High mobility group nucleosomal binding domain 2 (HMGN2) SUMOylation by the SUMO E3 ligase PIAS1 decreases the binding affinity to nucleosome core particles.The dynamics of HMG protein-chromatin interactions in living cells.Role of SUMO activating enzyme in cancer stem cell maintenance and self-renewal.Regulation of apoptosis by PML and the PML-NBs.Targeting promyelocytic leukemia protein: a means to regulating PML nuclear bodies Differential Roles of PML Isoforms.HMGA proteins as modulators of chromatin structure during transcriptional activation.Probing into the biological processes influenced by ESC factor and oncoprotein HMGA2 using iPSCs.PML: An emerging tumor suppressor and a target with therapeutic potential.

P2860

Q33637999-3FF3CEF2-27BD-4399-95B9-21AACD995EBD Q33931136-50809A50-B5B1-42DB-9011-90881C2E303E Q36282953-75876A1E-F600-419A-9842-4F949148E569 Q37153640-5F3DB2A9-DF30-449E-9E86-98140DA8C709 Q37302759-67FAB4EF-4551-4D34-822D-52419A273186 Q37496657-AA948B0D-A7DC-4F14-B5B2-CD59EADE7256 Q38111771-E915E569-D9BE-4164-B30A-B4F75B3ABFA9 Q38264460-91C0AD38-F296-4142-9F8B-F0E9A30F713E Q38497339-375D3836-6B23-4950-9B2C-87F76D7EB8F6 Q41971647-80355653-CBF2-4BA6-9C1B-F79618EDB97F

P2860

SUMOylation of HMGA2: selective destabilization of promyelocytic leukemia protein via proteasome.

http://www.wikidata.org/entity/Q33824136

description

2008 nî lūn-bûn

@nan

2008 թուականի Ապրիլին հրատարակուած գիտական յօդուած

@hyw

2008 թվականի ապրիլին հրատարակված գիտական հոդված

@hy

2008年の論文

@ja

2008年学术文章

@wuu

2008年学术文章

@zh-cn

2008年学术文章

@zh-hans

2008年学术文章

@zh-my

2008年学术文章

@zh-sg

2008年學術文章

@yue

name

SUMOylation of HMGA2: selectiv ...... ukemia protein via proteasome.

@ast

SUMOylation of HMGA2: selectiv ...... ukemia protein via proteasome.

@en

type

label

SUMOylation of HMGA2: selectiv ...... ukemia protein via proteasome.

@ast

SUMOylation of HMGA2: selectiv ...... ukemia protein via proteasome.

@en

prefLabel

SUMOylation of HMGA2: selectiv ...... ukemia protein via proteasome.

@ast

SUMOylation of HMGA2: selectiv ...... ukemia protein via proteasome.

@en

P1433

Q33824136-E97883BC-975D-4956-895B-2257360857C8

P1476

Q33824136-C18970DF-4BC3-487D-96D0-603CDC6A07DC

P2093

Q33824136-06625BDC-349B-415E-A736-3C588B7028AA

Q33824136-175A83B4-4D0F-493E-B93D-583B6E609054

Q33824136-49B638E5-4682-43CD-8251-CEA87C44E6A4

Q33824136-5F759DAD-4C14-4D5E-8CD0-97B5C8398341

Q33824136-687B26AE-5631-4285-975F-45641AF76CA7

Q33824136-A22AAA07-F17C-4E33-9291-7DFCC4865E69

Q33824136-CEAA290D-E867-4035-8AB8-2017FB7F5EBE

P2860

Q33824136-06779703-35AC-446A-A25D-89776FB56477

Q33824136-19AFBE19-FA25-482B-926D-BBABD724DF03

Q33824136-23945E07-05A8-4E31-96D3-5A35183FF851

Q33824136-293F59D6-CE42-4BB4-9F78-84DA5595A1CF

Q33824136-2971F231-778A-4E30-9DE4-063260BDD7D8

Q33824136-3645C6CA-7A48-4ACC-93D2-DB327942D4E0

Q33824136-37430874-C3BC-4F3B-9BA5-915D5213E873

Q33824136-374D9AEA-0013-4DE1-9D34-A99FFEBAAB4A

Q33824136-3EDBC6B3-33CE-4D7C-A1F2-7A9750F0F1C9

Q33824136-40B101A4-16CC-4745-82CD-E048146D70D7

P304

Q33824136-89DC6087-F6D0-498A-866A-5F3712A60DCA

P31

Q33824136-AFB22555-65EC-4805-BE81-0749633A3FF5

P356

Q33824136-109C3790-C2F0-4EF0-8B1B-B3BBED0F4FF6

P433

Q33824136-E6D04D6A-C4DA-4D24-8431-E2935157082C

P478

Q33824136-34C31C17-2A76-4F38-A993-8E89DD21DDB3

P577

Q33824136-4A446CF6-0A17-4EB1-9C99-F6CC388EC087

P5875

Q33824136-421B09A0-AAA3-472B-969B-738D2CB47424

P698

Q33824136-91F338F5-305A-4D70-BBCE-437B7B30C2AA

P921

Q33824136-DCE575DF-BDA8-438F-BD97-34F2C3CA7174

P932

Q33824136-3EBC5C5B-D9FF-4F93-8A6F-789E0A399A14

P356

1535-7163.MCT-07-0540

P1433

Molecular Cancer Therapeutics

P1476

SUMOylation of HMGA2: selectiv ...... ukemia protein via proteasome.

@en

P2093

Carlos Clavijo

http://www.w3.org/2001/XMLSchema#string

David K Ann

http://www.w3.org/2001/XMLSchema#string

H Helen Lin

http://www.w3.org/2001/XMLSchema#string

Hsiu-Ming Shih

http://www.w3.org/2001/XMLSchema#string

Xu Li

http://www.w3.org/2001/XMLSchema#string

Xuefei Cao

http://www.w3.org/2001/XMLSchema#string

Yuan Chen

http://www.w3.org/2001/XMLSchema#string

P2860

Role of SUMO-1-modified PML in nuclear body formation

HMGA2 induces pituitary tumorigenesis by enhancing E2F1 activity

Suppression of alternative lengthening of telomeres by Sp100-mediated sequestration of the MRE11/RAD50/NBS1 complex.

Differential regulation of the insulin-like growth factor II mRNA-binding protein genes by architectural transcription factor HMGA2

A CK2-dependent mechanism for degradation of the PML tumor suppressor

A novel role for high-mobility group a proteins in cellular senescence and heterochromatin formation

Transcriptional activation of the cyclin A gene by the architectural transcription factor HMGA2

PML colocalizes with and stabilizes the DNA damage response protein TopBP1

High mobility group A2 potentiates genotoxic stress in part through the modulation of basal and DNA damage-dependent phosphatidylinositol 3-kinase-related protein kinase activation

ZIP kinase triggers apoptosis from nuclear PML oncogenic domains

P304

923-934

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1158/1535-7163.MCT-07-0540

http://www.w3.org/2001/XMLSchema#string

P433

4

http://www.w3.org/2001/XMLSchema#string

P478

7

http://www.w3.org/2001/XMLSchema#string

P577

2008-04-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

5438505

http://www.w3.org/2001/XMLSchema#string

P698

18413806

http://www.w3.org/2001/XMLSchema#string

P921

P932

2862987

http://www.w3.org/2001/XMLSchema#string